Federal Register of Legislation - Australian Government

Primary content

PB 2 of 2012 Determinations/Health as made
This Determination amends the National Health (Price and Special Patient Contribution) Determination 2010 (No. PB 109 of 2010) to remove one brand of a pharmaceutical item.
Administered by: Health
Registered 13 Feb 2012
Tabling HistoryDate
Tabled HR15-Feb-2012
Tabled Senate27-Feb-2012
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

PB 2 of 2012

National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 1)1

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 7 February 2012

 

 

 

 

 

 

 

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing


 


1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 1).

            (2)        This Instrument may also be cited as PB 2 of 2012.

2          Commencement

            This Instrument commences on 1 March 2012.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).



Schedule 1     Amendments

 

[1]       Schedule 1, entry for Famotidine

omit:

 

Tablet 20 mg

Oral

Pepcidine M

60

9.08

13.17

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.